Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Christian Morath, MD, Anita Schmitt, MD, Christian Kleist, PhD, Volker Daniel, MD, Gerhard Opelz, MD, Caner Süsal, MD, Florian Kälble, MD, Claudia Sommerer, MD, Lei Wang, MD, Angela Hückelhoven, PhD, Arianeb Mehrabi, MD, Uta Merle, MD, Luiza Pego da Silva, Carsten Müller-Tidow, MD, Martin Zeier, MD, Matthias Schaier, MD, Michael Schmitt, MD PhD, Peter Terness, MD

Blood (2018) 132 (Supplement 1): 4539.

https://doi.org/10.1182/blood-2018-99-113386

Published: 2018

Journal Articles

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Joseph R. Leventhal, MD PhD, John P. Galvin, MDMS,MPH, James Mathew, PhD, Lorenzo Gallon, MD, Kadiyala Ravindra, MD, Mitchell E. Horwitz, MD, Michael Abecassis, MD, MBA, Suzanne T Ildstad, MD

Blood (2018) 132 (Supplement 1): 202.

https://doi.org/10.1182/blood-2018-99-118832

Published: 2018

Journal Articles

Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants

Samuel Strober

Blood (2016) 127 (12): 1539–1543.

https://doi.org/10.1182/blood-2015-12-685107

Published: 2016

Journal Articles

Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer

Joseph Leventhal, Michael Abecassis, M.D., Joshua Miller, M.D., Lorenzo Gallon, M.D., Kadiyala Ravindra, M.D., David J Tollerud, MD, MPH, Bradley J King, Geoffrey Herzig, M.D., Roger Herzig, MD, Suzanne T Ildstad, MD

Blood (2011) 118 (21): 832.

https://doi.org/10.1182/blood.V118.21.832.832

Published: 2011

Journal Articles

Chimerism, Lymphocyte Recovery, and the Absence of Graft-Versus-Host Disease in Recipients of Mismatched Unrelated Combined Kidney and HSC Transplants for Tolerance Induction

Joseph Leventhal, Paul A Cardenas, Mary J Elliott, Suzanne T Ildstad

Blood (2011) 118 (21): 1969.

https://doi.org/10.1182/blood.V118.21.1969.1969

Published: 2011

Journal Articles

The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline

Nadine Shehata, MD, MSC, Heather Ann Hume, MD, Valerie Palda, MD, MSc, Ralph Meyer, MD, Patricia Campbell, MBChB, Peter Nickerson, MD, Tom D Blydt-Hansen, MD, Lori West, MD, PhD, Heather Ross, MD, Steven Martin, MD, Tom Waddell, MD, Carl Cardella, MD, Davi d Anderson, MD, MSc, John Freedman, MD, Kevork Peltekian, MD

Blood (2008) 112 (11): 4666.

https://doi.org/10.1182/blood.V112.11.4666.4666

Published: 2008

NARROW

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants

Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer

Chimerism, Lymphocyte Recovery, and the Absence of Graft-Versus-Host Disease in Recipients of Mismatched Unrelated Combined Kidney and HSC Transplants for Tolerance Induction

The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline

Email alerts

ASH Publications

American Society of Hematology

Induction of Donor-Specific Immune Tolerance with Clinical MIC Cell Infusion — a Phase I Study (TOL-1)

Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor — Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts

Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants

Durable Chimerism, Absence of Graft-Versus-Host Disease and the Induction of Donor Specific Tolerance in Recipients of HLA Disparate Living Donor Kidney Transplants and Therapeutic Cell Transfer

Chimerism, Lymphocyte Recovery, and the Absence of Graft-Versus-Host Disease in Recipients of Mismatched Unrelated Combined Kidney and HSC Transplants for Tolerance Induction

The Use of IVIG for Solid Organ Transplantation: An Evidence Based Practice Guideline

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only